Try Alerts Free   |   Login
Technology › Semiconductors And Related Devices

SLAB Price Correlated With Financials For Silicon Laboratories

Free historical financial statements for Silicon Laboratories Inc. See how revenue, income, cash flow, and balance sheet financials have changed over 47 quarters since 2011. Compare with SLAB stock chart to see long term trends.

SLAB Stock Compared to Quarterly

SLAB Income Statement

Revenue, Net:269817000
Revenue Per Share:7.9174
Cost of Goods & Services Sold:104232000
Gross Profit:165585000
Selling, General & Admin Expense:50738000
Research & Development Expense:84624000
Total Operating Expenses:135362000
Operating Income:33368000
Income Taxes:14188000
Net Income:20999000
Earnings Per Share, Basic:0.62
Shares Outstanding, Basic Avg:34079000

SLAB Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:4566000
Net Cash from Operations:44042000
Net Cash from Operations Per Share:1.2924
Repurchases/Buybacks Common Stock:102655000
Net Cash from Financing Activities:-103428000
Property, Plant & Equipment Purchases:7735000
Net Cash from Investing Activities:68676000
Net Change in Cash & Equivalents:-21573000

SLAB Balance Sheet

Cash and Cash Equivalents:483277000
Short-Term Investments:893131000
Accounts Receivable, Net:76672000
Total Current Assets:1625636000
Property, Plant & Equipment, Net:151610000
Total Assets:2336297000
Accounts Payable:81676000
Total Short-Term Liabilities:205701000
Total Liabilities:784653000

Major Holders (from 13F filings)

Investment Type
Value (x$1000)
increase or decrease
Blackrock Inc.
5,820,289 sh
339,948 sh
5,133,824 sh
-353,614 sh
Vanguard Group Inc
3,268,255 sh
-326,725 sh
State Street Corp
1,396,780 sh
10,566 sh
1,148,899 sh
-188,021 sh
Alliancebernstein L.P.
728,274 sh
2,232 sh
Wellington Management Group Llp
724,892 sh
487,498 sh
Geode Capital Management, LLC
714,024 sh
-29,255 sh
GW&K Investment Management, LLC
703,738 sh
12,774 sh
Eagle Asset Management Inc
563,422 sh
55,786 sh
Dimensional Fund Advisors LP
560,154 sh
17,510 sh
Macquarie Group Ltd
550,802 sh
6,259 sh
Federated Hermes, Inc.
525,676 sh
-11,227 sh
Loomis Sayles & Co L P
504,976 sh
-26,837 sh
Capital Research Global Investors
464,000 sh
45,000 sh
Northern Trust Corp
448,933 sh
-70,543 sh
Pathstone Family Office, LLC
439,448 sh
1,158 sh
Millennium Management LLC
419,821 sh
311,570 sh
Bank Of New York Mellon Corp
384,594 sh
-23,660 sh
Charles Schwab Investment Management Inc
378,237 sh
-26,711 sh
2. Significant Accounting Policies Basis of Presentation and Principles of Consolidation The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 31. Fiscal 2021 had 52 weeks. Fiscal 2020 had 53 weeks with the extra week occurring in the first quarter of the year. Fiscal 2019 had 52 weeks. Fiscal 2021, 2020 and 2019 ended on January 1, 2022, January 2, 2021 and December 28, 2019, respectively. The accompanying Consolidated Financial Statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Foreign Currency Transactions The Company’s foreign subsidiaries are considered to be extensions of the U.S. Company. The functional currency of the foreign subsidiaries is the U.S. dollar. Accordingly, gains and losses resulting from remeasuring transactions denominated in currencies other than U.S. dollars are included in interest income and other, net in the Consolidated Statements of Income. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. Fair Value of Financial Instruments The fair values of the Company’s financial instruments are recorded using a hierarchical disclosure framework based upon the level of subjectivity of the inputs used in measuring assets and liabilities. The three levels are described below: Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date. Level 2 - Inputs other than Level 1 that are directly or indirectly observable, such as quoted prices for similar assets or liabilities and quoted prices in less active markets. Level 3 - Inputs are unobservable for the asset or liability and are developed based on the best information available in the circumstances, which might include the Company’s own data. 2. Significant Accounting Policies (Continued) Cash and Cash Equivalents Cash and cash equivalents consist of cash deposits, certificates of deposit, money market funds and investments in debt securities with original maturities of ninety days or less when purchased. Investments The Company’s investments typically have original maturities greater than ninety days as of the date of purchase and are classified as either available-for-sale or trading securities. Investments in available-for-sale securities are reported at fair value, with unrealized gains and losses, net of tax, recorded as a component of accumulated other comprehensive income (loss) in the Consolidated Balance Sheet. Investments in trading securities are reported at fair value, with both realized and unrealized gains and losses recorded in interest income and other, net in the Consolidated Statement of Income. Investments in which the Company has the ability and intent, if necessary, to liquidate in order to support its current operations (including those with contractual maturities greater than one year from the date of purchase) are classified as short-term. The Company reviews its available-for-sale investments as of the end of each reporting period for declines in fair value based on the specific identification method. The Company records an allowance for credit loss when a decline in fair value is due to credit-related factors. The Company considers various factors in determining whether an investment is impaired, including the severity of the impair

Data imported from Silicon Laboratories Inc SEC filings. Check original filings before making any investment decision.